BNS Staff, writers and editors —

BioNews, the owner and publisher of this site, employs science writers and editors, most of whom have PhDs in the life sciences, as well as veteran journalists, who ensure stories are well-written and easy to understand. Our stories undergo a comprehensive fact-checking and editing process to confirm accuracy, objectiveness, and thoroughness in order to best serve our audience of patients and caregivers.

Articles by BioNews Staff

Hereditary Neuropathy Foundation Hosts FDA Patient-Focused Drug Development Meeting

Along with Chris Comish, President and CEO of Charcot-Marie-Tooth’s parent company BioNews Services, I recently had the opportunity to attend the FDA Patient-Focused Drug Development (PFDD) Meeting for Charcot-Marie-Tooth disease. Hosted by the Hereditary Neuropathy Foundation in conjunction with the Food and Drug Administration, this meeting was one in an ongoing…